Research Square · Nov 20, 2026

Senescence and Genotoxicity Signatures Across Clinical and Laboratory Outcomes in Patients at High Cardiovascular Risk: An Automated Machine Learning Study

By Kyryk V, Krasnienkov D, Ustymenko A et al.

Background. Cellular senescence, chromosomal instability, endothelial injury, and altered immune composition may jointly reflect biological aging and cardiometabolic dysfunction. We evaluated whether a fixed 12-biomarker panel provided reproducible feature-level clues for 11 pre-selected clinical and laboratory outcomes in a three-group cohort at high cardiovascular risk. Methods. The dataset included 90 patients suffered from acute coronary syndrome (ACS), divided equally into three groups (n = 30 each): pre-pandemic ACS (Group 1), ACS with concomitant laboratory-confirmed acute COVID-19 during the pandemic (Group 2), and ACS without concomitant acute COVID-19 during the COVID-19 pandemic period (Group 3). Four model families were evaluated separately using 5-fold cross-fitting repeated five times. All imputation, scaling, and model fitting were restricted to training folds. Feature evidence integrated held-out permutation importance, cross-fitted SHAP values, linear coefficient stability, Group+SEX-adjusted partial rank associations, within-group sensitivity analyses, and leave-one-group-out transportability. Results. The largest median improvements over Group+SEX baselines occurred for history of acute myocardial infarction with coronary revascularization procedures (Δ=0.161), glucose level (Δ=0.118), heart rate (Δ=0.096), and glycated hemoglobin percentage (Δ=0.091). Recurrent feature themes included senescence-associated heterochromatin foci and CD34 + progenitor cells for glycemic outcomes, micronuclei for heart rate and prior COVID-19, nucleoplasmic bridges for cardiac-history and inflammatory/immune outcomes, and CD31 hi circulating endothelial cells for leukocyte and granulocyte counts. Absolute performance remained weak for several outcomes despite stable feature rankings. Conclusions. Rather than predicting any single outcome with strong absolute accuracy, the same senescence and genotoxicity markers recurred as leading clues across metabolically, cardiac, and immunologically distinct outcomes, and did so consistently across three pathogenetic different cohorts. This cross-outcome stability suggests these markers may index a shared, stressor-independent dimension of cellular burden in ACS patients rather than outcome-specific biology, a hypothesis that warrants mechanistic follow-up.

doi.org/10.21203/rs.3.rs-11524324/v1Open accessBiomarkers

AgingResearch.News